Liang Su
About
Liang Su has authored 20 papers that have received a total of 842 indexed citations.
This includes 10 papers in Molecular Biology, 5 papers in Infectious Diseases and 4 papers in Oncology. The topics of these papers are COVID-19 Clinical Research Studies (3 papers), Peptidase Inhibition and Analysis (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Liang Su is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Peptidase Inhibition and Analysis (2 papers) and Nanoparticle-Based Drug Delivery (2 papers) and collaborates with scholars based in China and United States. Liang Su's co-authors include Dong Liang, Huan Xie, Cheng‐Bao Zhu, Jing Ma and Jianjun Paul Tian and has published in prestigious journals such as ACS Nano, PLoS ONE and Frontiers in Immunology
In The Last Decade
Explore authors with similar magnitude of impact
Top journals papers by Jita G. Hoogerduijn are published in Top fields papers by Ronald C. Peterson are about Top journals papers by R. Scherschlicht are published in Top countries impacted by papers by Ya‐Ju Yang Top countries impacted by papers by P.J. Maccabee Top authors papers by Erin V. W. Andrew are co-authored with Top journals papers by Kevin J. Schwartz are published in Top fields papers by Petra Tollet‐Egnell are about